Nonetheless, our analysis of TCGA data indicates that PC expression is significantly up in mutant IDH-expressing human tumors when compared to wild-type IDH, both in the low-grade and high-grade cohorts, highlighting the clinical significance of our observations. The gene discussed is IDH2; the disease is pachyonychia congenita.